Microbot Medical Inc. (MBOT) Stock

Microbot Medical Inc. (MBOT) is a Healthcare stock trading at $1.86 (as of 2026-06-18), with a market capitalization of $136.34M and a trailing P/E of -7.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Microbot Medical Inc. develops robotic devices for minimally invasive procedures, including endoluminal surgery systems. Its portfolio includes micro-robotic technologies such as devices for cerebrospinal shunt cleaning and endovascular interventions, supported by an R&D pipeline and patent portfolio, with work conducted through technology collaboration with Stryker.

Valuation — source: SEC EDGAR (first-party)
Price$1.86
Market Cap$136.34M
P/E Ratio-7.2
EV / EBITDA-7.7
Price / Book1.70
Price / Sales1202.57
DCF Value (model)$-3.26
DCF Upside vs Price-275.3%
Profitability & Growth — source: SEC EDGAR
Return on Equity-19.2%
Current Ratio22.59
Valuation vs Sector & Industry
Stock P/E-7.2
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-134.5%
vs Industry-122.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD CAPITAL MANAGEMENT LLC ($7.01M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOHarel Gadot
Employees20
CountryUS
IPO Date1992-03-25

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Streamex Corp. (STEX)
  • Apyx Medical Corporation (APYX)
  • Lucid Diagnostics Inc. (LUCD)
  • Pro-Dex, Inc. (PDEX)
  • Anika Therapeutics, Inc. (ANIK)
  • Rapid Micro Biosystems, Inc. (RPID)
  • Picard Medical, Inc. (PMI)
  • Seer, Inc. (SEER)
MBOT earnings history · MBOT institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.